Concepedia

Emmanuel Monnet

EM

9

Publications

309

Citations

9

H-Index

1999

Active since

Affiliations

Light Chain Bioscience (Switzerland)(Current)

Inserm

Université Paris Cité

Stanford University

Hôpital Saint-Louis

Emmanuel Monnet is an author at Light Chain Bioscience (Switzerland) specializing in extracellular matrix, matrix biology, and medicine.

ORCID

Top concepts

Publications per year

1999–2019

9

Publications

9

Evidence of NI‐0101 pharmacological activity, an anti‐TLR4 antibody, in a randomized phase I dose escalation study in healthy volunteers receiving LPS

Emmanuel Monnet, G Lapeyre, Eveline P. van Poelgeest et al. · Clinical Pharmacology & Therapeutics · 2016 · 75 citations

Efficacy and safety of NI-0101, an anti-toll-like receptor 4 monoclonal antibody, in patients with rheumatoid arthritis after inadequate response to methotrexate: a phase II study

Emmanuel Monnet, Ernest Choy, Iain B. McInnes et al. · Annals of the Rheumatic Diseases · 2019 · 69 citations · Full text

A New Platelet Receptor Specific to Type III Collagen

Emmanuel Monnet, Françoise Fauvel-Lafève · Journal of Biological Chemistry · 2000 · 55 citations · Full text

A specific anti-citrullinated protein antibody profile identifies a group of rheumatoid arthritis patients with a toll-like receptor 4-mediated disease

Eric Hatterer, Limin Shang, Pierre Simonet et al. · Arthritis Research & Therapy · 2016 · 34 citations · Full text

Prognostic biomarkers of IFNb therapy in multiple sclerosis patients

Sergio E. Baranzini, Lohith Madireddy, Anne Cromer et al. · Multiple Sclerosis Journal · 2014 · 24 citations · Full text

Rows per page

1–5 of 9